---
figid: PMC12009761__fphar-16-1553791-g009
figtitle: Drug action diagram
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12009761
filename: fphar-16-1553791-g009.jpg
figlink: /pmc/articles/PMC12009761/figure/F9/
number: F9
caption: Drug action diagram. Schematic diagram summarizing the proposed model for
  miltirone enhances the chemosensitivity of gastric cancer cells to cisplatin b via
  inhibiting PI3K/AKT pathway
papertitle: Miltirone enhances the chemosensitivity of gastric cancer cells to cisplatin
  by suppressing the PI3K/AKT signaling pathway
reftext: Yiping Wang, et al. Front Pharmacol. 2025;16(NA).
year: '2025'
doi: 10.3389/fphar.2025.1553791
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: gastric cancer | miltirone | combination therapy | cisplatin | PI3K/Akt
  signaling pathway
automl_pathway: 0.9519101
figid_alias: PMC12009761__F9
figtype: Figure
redirect_from: /figures/PMC12009761__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12009761__fphar-16-1553791-g009.html
  '@type': Dataset
  description: Drug action diagram. Schematic diagram summarizing the proposed model
    for miltirone enhances the chemosensitivity of gastric cancer cells to cisplatin
    b via inhibiting PI3K/AKT pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - miltirone
  - cisplatin
---
